skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Journal Publications by ADMDC Members

Click on the Expand plus sign sign to list the journal publications by year. Then click on the PubMed link for details of that publication.

Time Line

Expand All

2014

Collapse All | Expand All

 

  • Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med. 2014;370(4):311-21. [view publication]
  • O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, et al. Molecular neuropsychology: creation of test-specific blood biomarker algorithms. Dement Geriatr Cogn Disord. 2014;37(1-2):45-57. [view publication]

2013

Collapse All | Expand All

 

  • Doody RS, Aisen PS, Iwatsubo T. Semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013;369(17):1661. [view publication]
  • Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013;369(4):341-50. [view publication]
  • Ferris S, Cummings J, Christensen D, Doody R, Farlow M, Sabbagh M, et al. Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity. Alzheimers Res Ther. 2013;5(1):12. [view publication]
  • O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, et al. Molecular Neuropsychology: Creation of Test-Specific Blood Biomarker Algorithms. Dement Geriatr Cogn Disord. 2013;37(1-2):45-57. [view publication]
  • Pavlik V, Massman P, Barber R, Doody R. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls. J Alzheimers Dis. 2013;34(2):449-56. [view publication]
  • Rountree SD, Atri A, Lopez OL, Doody RS. Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimers Dement. 2013;9(3):338-45. [view publication]
  • Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, et al. Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response. BMC Geriatr. 2013;13:56. [view publication]
  • Senanarong V, Harnphadungkit K, Poungvarin N, Vannasaeng S, Chongwisal S, Chakorn T, et al. The dementia and disability project in Thai elderly: rational, design, methodology and early results. BMC Neurol. 2013;13:3. [view publication]
  • Spiegel R, Doody RS, Hendrix S, Kahle-Wrobleski K. Modeling the course of Alzheimer's disease to improve clinical trials: symposium report. Alzheimers Res Ther. 2013;5(3):29. [view publication]
  • Szigeti K, Lal D, Li Y, Doody RS, Wilhelmsen K, Yan L, et al. Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease. J Alzheimers Dis. 2013;33(2):517-23. [view publication]
  • Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, et al. Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013;9(4):438-44. [view publication]
  • Zhang X, Li L, Zhang X, Xie W, Li L, Yang D, et al. Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APP(Swe)/PS1(A246E) transgenic mice. Neurobiol Aging. 2013;34(3):663-78. [view publication]

2012

Collapse All | Expand All

 

  • Atri A, Rountree SD, Lopez OL, Doody RS. Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies. Neurodegener Dis. 2012;10(1-4):170-4. [view publication]
  • Balsis S, Unger AA, Benge JF, Geraci L, Doody RS. Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: A comparison of item response theory-based scores and total scores. Alzheimers Dement. 2012;8(4):288-94. [view publication]
  • Doody RS, Cummings JL, Farlow MR. Reviewing the role of donepezil in the treatment of Alzheimer's disease. Curr Alzheimer Res. 2012;9(7):773-81. [view publication]
  • Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine. Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. [view publication]
  • Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, et al. The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage. 2012;59(4):4196-200. [view publication]
  • Rountree SD, Chan W, Pavlik VN, Darby EJ, Doody RS. Factors that influence survival in a probable Alzheimer disease cohort. Alzheimers Res Ther. 2012;4(3):16. [view publication]

<2011

Collapse All | Expand All

 

  • Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, Dubois B, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011;76(3):280-6. [view publication]
  • Balsis S, Miller TM, Benge JF, Doody RS. Dementia staging across three different methods. Dement Geriatr Cogn Disord. 2011;31(5):328-33. [view publication]
  • Doody RS, Cole PE, Miller DS, Siemers E, Black R, Feldman H, et al. Global issues in drug development for Alzheimer's disease. Alzheimers Dement. 2011;7(2):197-207. [view publication]
  • Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li C, et al. Identifying amnestic mild cognitive impairment in primary care: a feasibility study. Clin Drug Investig. 2011;31(7):483-91. [view publication]
  • Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, Massman PJ, et al. An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population. Int J Geriatr Psychiatry. 2011;26(4):351-5. [view publication]
  • Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, et al. Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis. 2011;27(2):259-69. [view publication]
  • O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, et al. A blood-based algorithm for the detection of Alzheimer's disease. Dement Geriatr Cogn Disord. 2011;32(1):55-62. [view publication]
  • Pavlik VN, Doody RS. Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment. Alzheimers Res Ther. 2011;3(5):30. [view publication]
  • Shaw CA, Li Y, Wiszniewska J, Chasse S, Zaidi SN, Jin W, et al. Olfactory copy number association with age at onset of Alzheimer disease. Neurology. 2011;76(15):1302-9. [view publication]
  • Szigeti K, Doody RS. Should EOAD patients be included in clinical trials? Alzheimers Res Ther. 2011;3(1):4. [view publication]
  • Szigeti K, Doody RS. Should persons with autosomal dominant AD be included in clinical trials? Authors' response. Alzheimers Res Ther. 2011;3(3):19. [view publication]
  • Zhang X, Heng X, Li T, Li L, Yang D, Zhang X, et al. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer's disease transgenic mouse model. J Alzheimers Dis. 2011;24(4):739-49. [view publication]
  • Doody RS, Ferris S, Salloway S, Yijun S, Goldman R, Yikang X, et al. Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study. Am J Alzheimers Dis Other Demen. 2010;25(2):155-9. [view publication]
  • Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Correction: Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010;2(3):14. [view publication]
  • Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010;2(1):2. [view publication]
  • Doody RS. Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design. J Nutr Health Aging. 2010;14(4):299-302. [view publication]
  • Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology. 2010;74(12):956-64. [view publication]
  • Kunik ME, Snow AL, Davila JA, McNeese T, Steele AB, Balasubramanyam V, et al. Consequences of aggressive behavior in patients with dementia. J Neuropsychiatry Clin Neurosci. 2010;22(1):40-7. [view publication]
  • Kunik ME, Snow AL, Davila JA, Steele AB, Balasubramanyam V, Doody RS, et al. Causes of aggressive behavior in patients with dementia. J Clin Psychiatry. 2010;71(9):1145-52. [view publication]
  • Kwon OD, Khaleeq A, Chan W, Pavlik VN, Doody RS. Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample. Dement Geriatr Cogn Disord. 2010;30(6):486-91. [view publication]
  • O'Bryant SE, Lacritz LH, Hall J, Waring SC, Chan W, Khodr ZG, et al. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. Arch Neurol. 2010;67(6):746-9. [view publication]
  • O'Bryant SE, Waring SC, Hobson V, Hall JR, Moore CB, Bottiglieri T, et al. Decreased C-reactive protein levels in Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23(1):49-53. [view publication]
  • O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, et al. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol. 2010;67(9):1077-81. [view publication]
  • Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, et al. Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol. 2010;17(1):103-10. [view publication]
  • Wolk DA, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010;107(22):. [view publication]
  • Benge JF, Balsis S, Geraci L, Massman PJ, Doody RS. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease? Dement Geriatr Cogn Disord. 2009;28(1):63-9. [view publication]
  • Benge JF, Perrier ND, Massman PJ, Meyers CA, Kayl AE, Wefel JS. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J Int Neuropsychol Soc. 2009;15(6):1002-11. [view publication]
  • Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, et al. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology. 2009;72(18):1555-61. [view publication]
  • Doody RS. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease. Alzheimers Dement. 2009;5(2):133-6. [view publication]
  • Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, et al. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009;5(2):85-92. [view publication]
  • Na HR, Lee SH, Lee JS, Doody RS, Kim SY. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease. Dement Geriatr Cogn Disord. 2009;27(1):69-75. [view publication]
  • O'Bryant SE, Hobson V, Hall JR, Waring SC, Chan W, Massman P, et al. Brain-derived neurotrophic factor levels in Alzheimer's disease. J Alzheimers Dis. 2009;17(2):337-41. [view publication]
  • Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord. 2009;28(6):536-40. [view publication]
  • Pavlik VN, Greisinger AJ, Pool J, Haidet P, Hyman DJ. Does reducing physician uncertainty improve hypertension control? Rationale and methods. Circ Cardiovasc Qual Outcomes. 2009;2(3):257-63. [view publication]
  • Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS. Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res Ther. 2009;1(2):7. [view publication]
  • Rustveld LO, Pavlik VN, Jibaja-Weiss ML, Kline KN, Gossey JT, Volk RJ. Adherence to diabetes self-care behaviors in English- and Spanish-speaking Hispanic men. Patient Prefer Adherence. 2009;3:123-30. [view publication]
  • Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, et al. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Dis Assoc Disord. 2009;23(3):260-7. [view publication]
  • Snyder PJ, Papp KV, Bartkowiak J, Jackson CE, Doody RS. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors. Alzheimers Dement. 2009;5(2):122-4. [view publication]
  • Albo Z, Lerner AJ. The role of working memory impairment in ADHD: new therapeutic indications. J Pre-Clinical and Clinical Research. 2008;2:1-5. [view publication]
  • Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs Aging. 2008;25(2):163-74. [view publication]
  • Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Lancet. 2008;372(9634):207-15. [view publication]
  • Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM. Meta-analysis of six-month memantine trials in Alzheimer's disease. Alzheimers Dement. 2008;3(1):7-17. [view publication]
  • Doody RS. Cholinesterase inhibitors and memantine: best practices. CNS Spectr. 2008;13(10(Suppl 16)):34-5. [view publication]
  • Doody RS. We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer's disease drug development. Alzheimers Dement. 2008;4(1 Suppl 1):S21-5. [view publication]
  • Jack CR, Jr, Petersen RC, Grundman M, Jin S, Gamst A, et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008;29(9):1285-95. [view publication]
  • Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, et al. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement. 2008;4(2):145-53. [view publication]
  • Kelly PA, Dyer CB, Pavlik V, Doody R, Jogerst G. Exploring self-neglect in older adults: preliminary findings of the self-neglect severity scale and next steps. J Am Geriatr Soc. 2008;56 Suppl 2:S253-60. [view publication]
  • Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008;4(3):156-63. [view publication]
  • Naik AD, Teal CR, Pavlik VN, Dyer CB, McCullough LB. Conceptual challenges and practical approaches to screening capacity for self-care and protection in vulnerable older adults. J Am Geriatr Soc. 2008;56 Suppl 2:S266-70. [view publication]
  • O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, et al. Staging dementia using Clinical Dementia Rating Scale sum of boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol. 2008;65(8):1091-5. [view publication]
  • Sitburana O, Rountree S, Ondo WG. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs. J Neurol Sci. 2008;272(1-2):77-82. [view publication]
  • Yan JH, Rountree S, Massman P, Doody RS, Li H. Alzheimer's disease and mild cognitive impairment deteriorate fine movement control. J Psychiatr Res. 2008;42(14):1203-12. [view publication]
  • Atchison TB, Massman PJ, Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type. Arch Clin Neuropsychol. 2007;22(1):99-107. [view publication]
  • Barnes AS, Goodrick GK, Pavlik V, Markesino J, Laws DY, Taylor WC. Weight loss maintenance in African-American women: focus group results and questionnaire development. J Gen Intern Med. 2007;22(7):915-22. [view publication]
  • Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology. 2007;69(5):459-69. [view publication]
  • Brown AE, Pavlik VN, Shegog R, Whitney SN, Friedman LC, Romero C, et al. Association of spirituality and sobriety during a behavioral spirituality intervention for Twelve Step (TS) recovery. Am J Drug Alcohol Abuse. 2007;33(4):611-7. [view publication]
  • Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology. 2007;69(16):1622-34. [view publication]
  • Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg. 2007;133(8):820-6. [view publication]
  • Hyman DJ, Pavlik VN, Taylor WC, Goodrick GK, Moye L. Simultaneous vs sequential counseling for multiple behavior change. Arch Intern Med. 2007;167(11):1152-8. [view publication]
  • Lin G, Spann S, Hyman D, Pavlik V. Climate amenity and BMI. Obesity (Silver Spring). 2007;15(8):2120-7. [view publication]
  • Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord. 2007;24(5):375-9. [view publication]
  • Rountree SD, Waring SC, Chan WC, Lupo PJ, Darby EJ, Doody RS. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia. Dement Geriatr Cogn Disord. 2007;24(6):476-82. [view publication]
  • Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med. 2007;33(5):428-434. [view publication]
  • Dyer CB, Kelly PA, Pavlik VN, Lee J, Doody RS, Regev T, et al. The making of a self-neglect severity scale. J Elder Abuse Negl. 2006;18(4):13-23. [view publication]
  • Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, et al. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmacother. 2006;4 Suppl A:S9-S24; quiz S25-S28. [view publication]
  • Gavagan TF, Smart K, Palacio H, Dyer C, Greenberg S, Sirbaugh P, et al. Hurricane Katrina: medical response at the Houston Astrodome/Reliant Center Complex. South Med J. 2006;99(9):933-9. [view publication]
  • Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, et al. Realistic expectations for treatment success in Alzheimer's disease. J Nutr Health Aging. 2006;10(5):417-29. [view publication]
  • Pavlik VN, Doody RS, Massman PJ, Chan W. Influence of premorbid IQ and education on progression of Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;22(4):367-77. [view publication]
  • Pavol M, Hiscock M, Massman P, Moore Iii B, Foorman B, Meyers C. Neuropsychological function in adults with von Recklinghausen's neurofibromatosis. Dev Neuropsychol. 2006;29(3):509-26. [view publication]
  • Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol. 2006;63(1):49-54. [view publication]
  • Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, et al. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):S124-38. [view publication]
  • Spann SJ, Nutting PA, Galliher JM, Peterson KA, Pavlik VN, Dickinson LM, et al. Management of type 2 diabetes in the primary care setting: a practice-based research network study. Ann Fam Med. 2006;4(1):23-31. [view publication]
  • Bitondo Dyer C, Toronjo C, Cunningham M, Festa NA, Pavlik VN, Hyman DJ, et al. The key elements of elder neglect:a survey of adult protective service workers. J Elder Abuse Negl. 2005;17(4):1-10. [view publication]
  • Doody R, Pavlik V, Massman P, Kenan M, Yeh S, Powell S, et al. Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dement Geriatr Cogn Disord. 2005;20(2-3):198-208. [view publication]
  • Doody RS. Refining treatment guidelines in Alzheimer's disease. Geriatrics. 2005;Suppl:14-20. [view publication]
  • Graham DP, Kunik ME, Doody R, Snow AL. Self-reported awareness of performance in dementia. Brain Res Cogn Brain Res. 2005;25(1):144-52. [view publication]
  • Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol. 2005;62(3):454-9. [view publication]
  • Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology. 2005;24(1-2):42-50. [view publication]
  • Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379-88. [view publication]
  • Roman GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord. 2005;20(6):338-44. [view publication]
  • Snow AL, Graham DP, Molinari VA, Orengo CA, Doody RS, Norris MP, et al. Factors affecting deficit awareness in persons with dementia. Dement Geriatr Cogn Disord. 2005;20(2-3):133-9. [view publication]
  • Snow AL, Kunik ME, Molinari VA, Orengo CA, Doody R, Graham DP, et al. Accuracy of self-reported depression in persons with dementia. J Am Geriatr Soc. 2005;53(3):389-96. [view publication]
  • Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W. Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord. 2005;19(4):178-83. [view publication]
  • Albo Z, Di Prisco GV, Chen Y, Rangarajan G, Truccolo W, Feng J, et al. Is partial coherence a viable technique for identifying generators of neural oscillations? Biol Cybern. 2004;90(5):318-26. [view publication]
  • Atchison TB, Bradshaw M, Massman PJ. Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data. Arch Clin Neuropsychol. 2004;19(8):1007-15. [view publication]
  • Doody R, Wirth Y, Schmitt F, Mobius HJ. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord. 2004;18(2):227-32. [view publication]
  • Doody RS, Dunn JK, Huang E, Azher S, Kataki M. A method for estimating duration of illness in Alzheimer's disease. Dement Geriatr Cogn Disord. 2004;17(1-2):1-4. [view publication]
  • Graham DP, Cully JA, Snow AL, Massman P, Doody R. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord. 2004;18(4):236-40. [view publication]
  • Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61(1):59-66. [view publication]
  • Pavlik VN, Hyman DJ, Wendt JA, Orengo C. Association of a culturally defined syndrome (nervios) with chest pain and DSM-IV affective disorders in Hispanic patients referred for cardiac stress testing. Ethn Dis. 2004;14(4):505-14. [view publication]
  • Snow AL, Norris MP, Doody R, Molinari VA, Orengo CA, Kunik ME. Dementia Deficits Scale. Rating self-awareness of deficits. Alzheimer Dis Assoc Disord. 2004;18(1):22-31. [view publication]
  • Albo Z, Di Prisco GV, Vertes RP. Anterior thalamic unit discharge profiles and coherence with hippocampal theta rhythm. Thalamus Relat Syst. 2003;2:133-44. [view publication]
  • Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, et al. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol. 2003;60(12):1696-702. [view publication]
  • Davis RN, Massman PJ, Doody RS. Effects of blood pressure on neuropsychological functioning in Alzheimer's disease. Arch Clin Neuropsychol. 2003;18(1):19-32. [view publication]
  • Davis RN, Massman PJ, Doody RS. WAIS-R factor structure in Alzheimer's disease patients: a comparison of alternative models and an assessment of their generalizability. Psychol Aging. 2003;18(4):836-43. [view publication]
  • Doody RS. Current treatments for Alzheimer's disease: cholinesterase inhibitors. J Clin Psychiatry. 2003;64 Suppl 9:11-7. [view publication]
  • Doody RS. Update on Alzheimer drugs (donepezil). Neurologist. 2003;9(5):225-9. [view publication]
  • Hyman DJ, Pavlik VN. Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention. Curr Atheroscler Rep. 2003;5(2):131-8. [view publication]
  • Pavlik VN, de Moraes SA, Szklo M, Knopman DS, Mosley TH, Jr, et al. Relation between cognitive function and mortality in middle-aged adults: the atherosclerosis risk in communities study. Am J Epidemiol. 2003;157(4):327-34. [view publication]
  • Pavlik VN, Hyman DJ. How well are we managing and monitoring high blood pressure? Curr Opin Nephrol Hypertens. 2003;12(3):299-304. [view publication]
  • Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003;348(14):1333-41. [view publication]
  • Richardson KA, Gluckman BJ, Weinstein SL, Glosch CE, Moon JB, Gwinn RP, et al. In vivo modulation of hippocampal epileptiform activity with radial electric fields. Epilepsia. 2003;44(6):768-77. [view publication]
  • Smith RG, Roher AE, Appel SH, Doody RS, Killian JM, Corey-Bloom J, et al. Autonomic sudomotor dysfunction in Alzheimer's disease. Curr Med Chem - Imun Endoc Metab Agents. 2003;3(1):77-84. [view publication]
  • Wayne DB, Greenberg SB, Pavlik VN, Helmer DA, Hyman DJ. Ambulatory internal medicine education: use of an urgent care center. South Med J. 2003;96(9):876-9. [view publication]
  • Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61(4):479-86. [view publication]
  • Harrell R, Toronjo CH, McLaughlin J, Pavlik VN, Hyman DJ, Dyer CB. How geriatricians identify elder abuse and neglect. Am J Med Sci. 2002;323(1):34-8. [view publication]
  • Hyman DJ, Pavlik VN. Poor hypertension control: let's stop blaming the patients. Cleve Clin J Med. 2002;69(10):793-9. [view publication]
  • Kusek JW, Ahrens A, Burrows PK, Clarke HS, Foster HE, Hanson K, et al. Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia. Urology. 2002;59(1):63-7. [view publication]
  • Li D, Ronson B, Guo M, Liu S, Bishop JS, Van Echo DA, et al. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer. Cancer Res. 2002;62(14):4023-8. [view publication]
  • Poston WS, Haddock CK, Spertus J, Catanese DM, Pavlik VN, Hyman DJ, et al. Physical activity does not mitigate G-protein-related genetic risk for obesity in individuals of African descent. Eat Weight Disord. 2002;7(1):68-71. [view publication]
  • Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, et al. A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial. Neurology. 2002;58(3):433-7. [view publication]
  • Viana Di Prisco G, Albo Z, Vertes RP, Kocsis B. Discharge properties of neurons of the median raphe nucleus during hippocampal theta rhythm in the rat. Exp Brain Res. 2002;145(3):383-94. [view publication]
  • Weiner MF, Doody RS, Sairam R, Foster B, Liao TY. Prevalence and incidence of major depressive disorder in Alzheimer's disease: findings from two databases. Dement Geriatr Cogn Disord. 2002;13(1):8-12. [view publication]
  • Davis RN, Massman PJ, Doody RS. Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study. Alzheimer Dis Assoc Disord. 2001;15(1):1-9. [view publication]
  • Doody RS, Dunn JK, Clark CM, Farlow M, Foster NL, Liao T, et al. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord. 2001;12(4):295-300. [view publication]
  • Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol. 2001;58(3):427-33. [view publication]
  • Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol. 2001;58(3):449-54. [view publication]
  • Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1154-66. [view publication]
  • Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7):479-86. [view publication]
  • Li D, Shugert E, Guo M, Bishop JS, O'Malley BW, Jr. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127(11):1319-24. [view publication]
  • Li D, Zeiders JW, Liu S, Guo M, Xu Y, Bishop JS, et al. Combination nonviral cytokine gene therapy for head and neck cancer. Laryngoscope. 2001;111(5):815-20. [view publication]
  • Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology. 2001;57(3):481-8. [view publication]
  • Pavlik VN, Hyman DJ, Festa NA, Bitondo Dyer C. Quantifying the problem of abuse and neglect in adults--analysis of a statewide database. J Am Geriatr Soc. 2001;49(1):45-8. [view publication]
  • Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985-92. [view publication]
  • Poston WS, Pavlik VN, Hyman DJ, Ogbonnaya K, Hanis CL, Haddock CK, et al. Genetic bottlenecks, perceived racism, and hypertension risk among African Americans and first-generation African immigrants. J Hum Hypertens. 2001;15(5):341-51. [view publication]
  • Sharma MD, Pavlik VN. Dyslipidaemia in African Americans, Hispanics and whites with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab. 2001;3(1):41-5. [view publication]
  • Tangalos E, Doody R, Tariot P. Alzheimer's disease in long-term care: maximizing treatment options. J Am Med Dir Assoc. 2001;2(4):H17-20. [view publication]
  • Vertes RP, Albo Z, Viana Di Prisco G. Theta-rhythmically firing neurons in the anterior thalamus: implications for mnemonic functions of Papez's circuit. Neuroscience. 2001;104(3):619-25. [view publication]
  • Bishop JS, Thull NM, Matar M, Quezada A, Munger WE, Batten TL, et al. Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil. Cancer Gene Ther. 2000;7(8):1165-71. [view publication]
  • Cirino PT, Chapieski LM, Massman PJ. Card sorting performance and ADHD symptomatology in children and adolescents with tourette syndrome. J Clin Exp Neuropsychol. 2000;22(2):245-56. [view publication]
  • Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2000;69(5):668-71. [view publication]
  • Doody RS. Mortality from pneumonia and hip fractures in patients with advanced dementia. Jama. 2000;284(19):2447; author reply 2448. [view publication]
  • Doody RS. The issue of representation in brain research. Brain Cogn. 2000;42(1):26-8. [view publication]
  • Dyer CB, Pavlik VN, Murphy KP, Hyman DJ. The high prevalence of depression and dementia in elder abuse or neglect. J Am Geriatr Soc. 2000;48(2):205-8. [view publication]
  • Hanna PA, Doody RS. Alien limb sign. Adv Neurol. 2000;82:135-45. [view publication]
  • Hyman DJ, Ogbonnaya K, Pavlik VN, Poston WS, Ho K. Lower hypertension prevalence in first-generation African immigrants compared to US-born African Americans. Ethn Dis. 2000;10(3):343-9. [view publication]
  • Hyman DJ, Ogbonnaya K, Taylor AA, Ho K, Pavlik VN. Ethnic differences in nocturnal blood pressure decline in treated hypertensives. Am J Hypertens. 2000;13(8):884-91. [view publication]
  • Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich). 2000;2(5):324-330. [view publication]
  • Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160(15):2281-6. [view publication]
  • Mendiratta SK, Quezada A, Matar M, Thull NM, Bishop JS, Nordstrom JL, et al. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Hum Gene Ther. 2000;11(13):1851-62. [view publication]
  • Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Jama. 2000;283(8):1007-15. [view publication]
  • Pavlik VN, Hyman DJ, Toronjo C. Comparison of automated and mercury column blood pressure measurements in health care settings. J Clin Hypertens (Greenwich). 2000;2(2):81-86. [view publication]
  • Rogers SL, Doody RS, Pratt RD, Ieni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol. 2000;10(3):195-203. [view publication]
  • Balasubramanyam A, McKay S, Nadkarni P, Rajan AS, Garza A, Pavlik V, et al. Ethnicity affects the postprandial regulation of glycogenolysis. Am J Physiol. 1999;277(5 Pt 1):E905-14. [view publication]
  • Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med. 1999;159(19):2317-22. [view publication]
  • Blezinger P, Yin G, Xie L, Wang J, Matar M, Bishop JS, et al. Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models. Angiogenesis. 1999;3(3):205-10. [view publication]
  • Doody RS, Strehlow SL, Massman PJ, Feher EP, Clark C, Roy JR. Baylor profound mental status examination: a brief staging measure for profoundly demented Alzheimer disease patients. Alzheimer Dis Assoc Disord. 1999;13(1):53-9. [view publication]
  • Doody RS, Vacca JL, Massman PJ, Liao TY. The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease. Arch Neurol. 1999;56(9):1133-7. [view publication]
  • Doody RS. Clinical benefits of a new piperidine-class AChE inhibitor. Eur Neuropsychopharmacol. 1999;9 Suppl 2:S69-77. [view publication]
  • Doody RS. Clinical profile of donepezil in the treatment of Alzheimer's disease. Gerontology. 1999;45 Suppl 1:23-32. [view publication]
  • Doody RS. Therapeutic standards in Alzheimer disease. Alzheimer Dis Assoc Disord. 1999;13 Suppl 2:S20-6. [view publication]
  • Dyer CB, Gleason MS, Murphy KP, Pavlik VN, Portal B, Regev T, et al. Treating elder neglect: collaboration between a geriatrics assessment team and adult protective services. South Med J. 1999;92(2):242-4. [view publication]
  • Konrad M, Pavlik V, Mares P. Kainic acid increases activity only of some cortical neurons in the rat. Physiol Res. 1999;48(5):395-8. [view publication]
  • Li D, Jiang W, Bishop JS, Ralston R, O'Malley BW, Jr. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer. Clin Cancer Res. 1999;5(6):1551-6. [view publication]
  • Sherman AM, Massman PJ. Prevalence and correlates of category versus letter fluency discrepancies in Alzheimer's disease. Arch Clin Neuropsychol. 1999;14(5):411-8. [view publication]
  • Coleman M, Muller S, Quezada A, Mendiratta SK, Wang J, Thull NM, et al. Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response. Hum Gene Ther. 1998;9(15):2223-30. [view publication]
  • Doody R, Whitehouse PJ, Chen Q, Wang L, Wu Q, Rosser M, et al. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1998;12(4):263-5. [view publication]
  • Doody RS, Massman PJ, Mawad M, Nance M. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11(4):191-9. [view publication]
  • Hyman DJ, Pavlik VN, Vallbona C, Dunn JK, Louis K, Dewey CM, et al. Blood pressure measurement and antihypertensive treatment in a low-income African-American population. Am J Public Health. 1998;88(2):292-4. [view publication]
  • Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998;158(9):1021-31. [view publication]
  • Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998;50(1):136-45. [view publication]
  • Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:19-21. [view publication]
  • Antuono P, Doody R, Gilman S, Huff J, Scheltens P, Ueda K, et al. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:22-5. [view publication]
  • Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease. Neurology. 1997;49(1):70-5. [view publication]
  • Doody RS. Treatment of Alzheimer's disease. Neurologist. 1997;3(6):333-43. [view publication]
  • Pavlik VN, Hyman DJ, Vallbona C, Toronjo C, Louis K. Hypertension awareness and control in an inner-city African-American sample. J Hum Hypertens. 1997;11(5):277-83. [view publication]
  • Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW. Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology. 1997;49(1):44-50. [view publication]
  • Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, et al. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:8-18. [view publication]
  • Sabbagh MN, Lynn P, Jhingran S, Massman P, Villanueva-Meyer J, Olup J, et al. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1997;9(1):68-74. [view publication]
  • Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S22-32. [view publication]
  • Strite D, Massman PJ, Cooke N, Doody RS. Neuropsychological asymmetry in Alzheimer's disease: verbal versus visuoconstructional deficits across stages of dementia. J Int Neuropsychol Soc. 1997;3(5):420-7. [view publication]
  • Thal LJ, Carta A, Doody R, Leber P, Mohs R, Schneider L, et al. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:46-9. [view publication]
  • Bishop JS, Guy-Caffey JK, Ojwang JO, Smith SR, Hogan ME, Cossum PA, et al. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J Biol Chem. 1996;271(10):5698-703. [view publication]
  • Kadmon D, Weinberg AD, Williams RH, Pavlik VN, Cooper P, Migliore PJ. Pitfalls in interpreting prostate specific antigen velocity. J Urol. 1996;155(5):1655-7. [view publication]
  • Kataki M, Winikates J, Kirkpatrick J, Doody RS. Longitudinal study of aphasia in Creutzfeldt-Jakob disease. Neuropsychiatry Neuropsychol Behav Neurol. 1996;9(4):284-7. [view publication]
  • Massman PJ, Doody RS. Hemispheric asymmetry in Alzheimer's disease is apparent in motor functioning. J Clin Exp Neuropsychol. 1996;18(1):110-21. [view publication]
  • Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology. 1996;46(3):720-6. [view publication]
  • Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1996;61(5):450-5. [view publication]
  • Olin JT, Schneider LS, Doody RS, Clark CM, Ferris SH, Morris JC, et al. Clinical evaluation of global change in Alzheimer's disease: identifying consensus. J Geriatr Psychiatry Neurol. 1996;9(4):176-80. [view publication]
  • Pavlik VN, Hyman DJ, Vallbona C, Dunn JK, Louis K, Dewey CM, et al. Response rates to random digit dialing for recruiting participants to an onsite health study. Public Health Rep. 1996;111(5):444-50. [view publication]
  • Pavlik VN, Hyman DJ, Vallbona C. Hypertension control in multi-ethnic primary care clinics. J Hum Hypertens. 1996;10 Suppl 3:S19-23. [view publication]
  • Pavlik VN, Nichaman MZ, Vallbona C. NIDDM incidence in a tri-ethnic population of diagnosed hypertensives. Ethn Dis. 1996;6(3-4):213-23. [view publication]
  • Doody RS, Massman P, Mahurin R, Law S. Positive and negative neuropsychiatric features in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1995;7(1):54-60. [view publication]
  • Guy-Caffey JK, Bodepudi V, Bishop JS, Jayaraman K, Chaudhary N. Novel polyaminolipids enhance the cellular uptake of oligonucleotides. J Biol Chem. 1995;270(52):31391-6. [view publication]
  • Kotrla KJ, Chacko RC, Harper RG, Doody R. Clinical variables associated with psychosis in Alzheimer's disease. Am J Psychiatry. 1995;152(9):1377-9. [view publication]
  • Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R. SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry. 1995;152(10):1470-5. [view publication]
  • Buritova J, Hrabetova S, Hrabe J, Mares P, Pavlik V. Influence of carbamazepine and phenytoin on spontaneous activity of cerebellar neurons. Physiol Res. 1994;43(2):113-6. [view publication]
  • Peavy G, Jacobs D, Salmon DP, Butters N, Delis DC, Taylor M, et al. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol. 1994;16(4):508-23. [view publication]
  • Shaibani A, Sabbagh M, Doody RS. Laughter and crying in neurologic disorders. Neuropsychiatry Neuropsychol Behav Neurol. 1994;7(4):243-50. [view publication]
  • Aruffo JF, Coverdale JH, Pavlik VN, Vallbona C. AIDS knowledge in minorities: significance of locus of control. Am J Prev Med. 1993;9(1):15-20. [view publication]
  • Baker SB, Vallbona C, Pavlik V, Fasser CE, Armbruster M, McCray R, et al. A diabetes control program in a public health care setting. Public Health Rep. 1993;108(5):595-605. [view publication]
  • Bishop JS, Burton RS. Amino acid synthesis during hyperosmotic stress in Penaeus aztecus postlarvae. Comp Biochem Physiol. 1993;106A:49-56.
  • Doody RS. A reappraisal of localization theory with reference to aphasia. Part 1: historical considerations. Brain Lang. 1993;44(3):296-326. [view publication]
  • Doody RS. A reappraisal of localization theory with reference to aphasia. Part 2: language theories from outside neurology. Brain Lang. 1993;44(3):327-48. [view publication]
  • Massman PJ, Bigler ED. A quantitative review of the diagnostic utility of the WAIS-R Fuld profile. Arch Clin Neuropsychol. 1993;8(5):417-28. [view publication]
  • Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med. 1992;327(18):1253-9. [view publication]
  • Delis DC, Massman PJ, Butters N, Salmon DP, Shear PK, Demadura T, et al. Spatial cognition in Alzheimer's disease: subtypes of global-local impairment. J Clin Exp Neuropsychol. 1992;14(4):463-77. [view publication]
  • Delis DC, Squire LR, Bihrle A, Massman P. Componential analysis of problem-solving ability: performance of patients with frontal lobe damage and amnesic patients on a new sorting test. Neuropsychologia. 1992;30(8):683-97. [view publication]
  • Doody RS, Hrachovy RA, Feher EP. Recurrent fluent aphasia associated with a seizure focus. Brain Lang. 1992;42(4):419-30. [view publication]
  • Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 1992;55(9):806-10. [view publication]
  • Doody RS. Sense and non-sense: dissemination and empiricism in practice. Ethos. 1992;20(2):220-9. [view publication]
  • Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the Mini-Mental State. Examination of 'subtests'. Arch Neurol. 1992;49(1):87-92. [view publication]
  • Filoteo JV, Delis DC, Massman PJ, Demadura T, Butters N, Salmon DP. Directed and divided attention in Alzheimer's disease: impairment in shifting of attention to global and local stimuli. J Clin Exp Neuropsychol. 1992;14(6):871-83. [view publication]
  • Massman PJ, Delis DC, Butters N, Dupont RM, Gillin JC. The subcortical dysfunction hypothesis of memory deficits in depression: neuropsychological validation in a subgroup of patients. J Clin Exp Neuropsychol. 1992;14(5):687-706. [view publication]
  • Vallbona C, Pavlik V. Advances in the community control of hypertension: from epidemiology to primary care practice. J Hypertens Suppl. 1992;10(7):S51-7. [view publication]
  • Doody RS. Aphasia as postmodern (anthropological) discourse. J Anthropol Res. 1991;47(3):285-303. [view publication]
  • Feher EP, Doody RS, Whitehead J, Pirozzolo FJ. Progressive nonfluent aphasia with dementia: a case report. J Geriatr Psychiatry Neurol. 1991;4(4):236-40. [view publication]
  • Pavlik VN, Rankin BB, Vallbona C, Bacon RJ, Tristan MP. Factors related to medical school application and acceptance in minority summer enrichment program students. J Natl Med Assoc. 1991;83(7):628-32. [view publication]
  • Doody RS, Rosenfield DB. Spasmodic dysphonia associated with palatal myoclonus. Ear Nose Throat J. 1990;69(12):829-32. [view publication]
  • Massman PJ, Delis DC, Butters N, Levin BE, Salmon DP. Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J Clin Exp Neuropsychol. 1990;12(5):729-44. [view publication]
  • Feher EP, Doody R, Pirozzolo FJ, Appel SH. Mental status assessment of insight and judgment. Clin Geriatr Med. 1989;5(3):477-98. [view publication]
  • Massman PJ, Nussbaum NL, Bigler ED. The mediating effect of age on the relationship between Child Behavior Checklist hyperactivity scores and neuropsychological test performance. J Abnorm Child Psychol. 1988;16(1):89-95. [view publication]
  • Nussbaum NL, Bigler ED, Koch WR, Ingram JW, Rosa L, Massman P. Personality/behavioral characteristics in children: differential effects of putative anterior versus posterior cerebral asymmetry. Arch Clin Neuropsychol. 1988;3(2):127-35. [view publication]
  • Naugle RI, Cullum CM, Bigler ED, Massman PJ. Handedness and dementia. Percept Mot Skills. 1987;65(1):207-10. [view publication]
  • Massman PJ, Bigler ED, Cullum CM, Naugle RI. The relationship between cortical atrophy and ventricular volume. Int J Neurosci. 1986;30(1-2):87-99. [view publication]
  • Naugle RI, Cullum CM, Bigler ED, Massman PJ. Neuropsychological characteristics and atrophic brain changes in senile and presenile dementia. Arch Clin Neuropsychol. 1986;1(3):219-30. [view publication]
  • Berman JS, Miller RC, Massman PJ. Cognitive therapy versus systematic desensitization: is one treatment superior? Psychol Bull. 1985;97(3):451-61. [view publication]
  • Naugle RI, Cullum CM, Bigler ED, Massman PJ. Neuropsychological and computerized axial tomography volume characteristics of empirically derived dementia subgroups. J Nerv Ment Dis. 1985;173(10):596-604. [view publication]
  • Yusim S, Vallbona C, Pavlik V, Sanford S, Baron A, Merrill J. Failures in comprehensive diagnosis by senior medical students. J Med Educ. 1984;59(10):838-40. [view publication]
  • Ornish D, Scherwitz LW, Doody RS, Kesten D, McLanahan SM, Brown SE, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. Jama. 1983;249(1):54-9. [view publication]
  • Doody RS, Grose NP. The family medical history: assessing patient understanding of diabetes mellitus. Diabetes Care. 1981;4(2):285-8. [view publication]
  • Tristan MP, Pavlik VN, Rankin BB, Lester J, Vallbona C. Review of a program for premedical minority students. Tex Med. 1981;77(3):51-4. [view publication]

E-mail this page to a friend